Exodus Point Capital Management, LP Arrowhead Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 88,884 shares of ARWR stock, worth $1.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
88,884
Previous 71,015 25.16%
Holding current value
$1.9 Million
Previous $1.85 Million 6.72%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$19.36 - $29.54 $345,943 - $527,850
17,869 Added 25.16%
88,884 $1.72 Million
Q2 2024

Aug 13, 2024
BUY
$21.87 - $28.24 $51,788 - $66,872
2,368 Added 3.45%
71,015 $1.85 Million
Q1 2024

May 14, 2024
BUY
$27.21 - $39.48 $993,709 - $1.44 Million
36,520 Added 113.67%
68,647 $1.96 Million
Q3 2023

Nov 09, 2023
BUY
$26.2 - $36.08 $841,727 - $1.16 Million
32,127 New
32,127 $863,000
Q1 2023

May 11, 2023
SELL
$23.68 - $38.51 $461,878 - $751,137
-19,505 Reduced 58.46%
13,860 $352,000
Q4 2022

Feb 13, 2023
SELL
$28.0 - $40.56 $1.01 Million - $1.46 Million
-35,926 Reduced 51.85%
33,365 $1.35 Million
Q3 2022

Nov 10, 2022
BUY
$29.63 - $48.31 $654,763 - $1.07 Million
22,098 Added 46.82%
69,291 $2.29 Million
Q2 2022

Aug 19, 2022
BUY
$27.79 - $50.61 $1.13 Million - $2.06 Million
40,615 Added 617.44%
47,193 $1.66 Million
Q1 2022

May 13, 2022
SELL
$39.62 - $69.97 $2.06 Million - $3.64 Million
-51,989 Reduced 88.77%
6,578 $303,000
Q4 2021

Feb 11, 2022
BUY
$58.09 - $82.51 $2.46 Million - $3.5 Million
42,393 Added 262.11%
58,567 $3.88 Million
Q3 2021

Nov 15, 2021
BUY
$58.38 - $84.96 $282,675 - $411,376
4,842 Added 42.73%
16,174 $1.01 Million
Q2 2021

Aug 16, 2021
BUY
$62.15 - $90.32 $280,607 - $407,794
4,515 Added 66.23%
11,332 $939,000
Q1 2021

May 17, 2021
SELL
$61.35 - $90.47 $244,786 - $360,975
-3,990 Reduced 36.92%
6,817 $452,000
Q4 2020

Feb 16, 2021
BUY
$43.82 - $85.37 $473,562 - $922,593
10,807 New
10,807 $829,000
Q2 2020

Aug 14, 2020
SELL
$26.12 - $43.27 $370,825 - $614,304
-14,197 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$20.56 - $63.12 $154,590 - $474,599
-7,519 Reduced 34.62%
14,197 $408,000
Q4 2019

Feb 14, 2020
BUY
$28.14 - $73.01 $611,088 - $1.59 Million
21,716 New
21,716 $1.38 Million

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
91.2M
Call Options Held
130K
Put Options Held
401K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.27B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email